ABSTRACT
In the last few years, several models trying to calculate the biological brain age have been proposed based on structural magnetic resonance imaging scans (T1-weighted MRIs, T1w) using multivariate methods and artificial intelligence. We developed and validated a convolutional neural network (CNN)-based biological brain age prediction model that uses only one T1w MRI pre-processing step to simplify implementation and increase accessibility in research settings. Our model only requires rigid image registration to the MNI space, which is an advantage compared to previous methods that require more pre-processing steps, such as feature extraction. We used a multicohort dataset of cognitively healthy individuals (age range = 32.0 – 95.7 yrs.) comprising 17296 MRIs for training and evaluation. We compared our model using hold-out (CNN1) and cross-validation (CNN2-4) approaches. To verify generalizability, we used two external datasets with different population and MRI scan characteristics to evaluate the model. To demonstrate its usability, we included the external dataset’s images in the cross-validation training (CNN3). To ensure that our model used only the brain signal on the image, we also predicted brain age using skull-stripped images (CNN4). The trained models achieved a mean absolute error of 2.99, 2.67, 2.67, and 3.08 yrs. for the CNN1-4, respectively. The model’s performance in the external dataset was in the typical range of mean absolute error (MAE) found in the literature for testing sets. Adding the external dataset to the training set (CNN3), overall, MAE is unaffected, but individual cohort MAE improves (2.25 to 5.63 years). Salience maps of predictions reveal that periventricular, temporal, and insular regions are the most important for age prediction. We provide indicators for using biological (predicted) brain age as a metric for age correction in neuroimaging studies as an alternative to the traditional chronological age. In conclusion, using different approaches, our CNN-based model showed good performance using only one T1w brain MRI pre-processing step. The proposed CNN model is made publicly available for the research community to be easily implemented and used to study aging and age-related disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Swedish Research Council (VR), the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), the Center for Innovative Medicine (CIMED), the Foundation for Geriatric Diseases at Karolinska Institutet, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Swedish Brain Foundation, the Swedish Alzheimer Foundation, the Åke Wiberg Foundation, the Olle Engkvist Byggmastare Foundation, the joint research funds of KTH Royal Institute of Technology and Stockholm County Council (HMT), Swedish Parkinson Foundation, King Gustaf V:s and Queen Victorias Foundation, David and Astrid Hagelens Foundation, Loo and Hans Ostermans Foundation, Vinnova and Digital Futures for financial support, and the NIA-supported Collaboratory on Research Definitions for reserve and resilience in cognitive ageing and dementia. The Titan X Pascal used for this research was donated by the NVIDIA Corporation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Karolinska Institutet gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵1 Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
↵2 Data used in the preparation of this article was obtained from the Australian Imaging Biomarkers and Lifestyle flagship study of aging (AIBL) funded by the Commonwealth Scientific and Industrial Research Organisation (CSIRO), which was made available at the ADNI database (www.loni.usc.edu/ADNI). The AIBL researchers contributed data but did not participate in the analysis or writing of this report. AIBL researchers are listed at https://aibl.csiro.au/.
↵3 Data used in the preparation of this article were obtained from the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) database deposited in the National Bioscience Database Center Human Database, Japan (Research ID: hum0043.v1, 2016). As such, the investigators within J-ADNI contributed to the design and implementation of J-ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of J-ADNI investigators can be found at: https://humandbs.biosciencedbc.jp/en/hum0043-j-adni-authors.
In this new submission, we present a deeper comparison of the developed CNN model in four different approaches, including the hold-out approach, compared to the cross-validation of the same model, including more data, and additionally, the model's performance using skull-stripped images. We show the robust performance of our developed CNN with two external datasets. We still focus on using images only having a rigid registration to the Montreal Neurological Institute - MNI - template space as input to the model. This revised version does not present the previous comparison with the Orthogonal Partial Least Square (OPLS) model and focuses on the development of our CNN model.
Data Availability
The complete code for using the CNN is available at https://github.com/westman-neuroimaging-group/brainage-prediction-mri. We include all the developed models and their trained weights for researchers to apply on their own neuroimaging data sets (with and without skull-stripped T1w MRI brain images) and scripts for training their model on other datasets. When new image data is available from different cohorts, the CNN will be re-trained, and trained weights and performance of the model will be updated in the page.
https://github.com/westman-neuroimaging-group/brainage-prediction-mri